Clinical Trials Directory

Trials / Unknown

UnknownNCT06303531

Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years

An Interventional, Single-Center, Randomized, Unblinded, Parallel-Group, Three-Arm Study to Investigate the Superiority of 12 Weeks of Oral Treatment With Ferrous Ascorbate (EBMfer) or Ferrous Fumarate (Eurofer) as Compared to Polysaccharide Iron (FeraMAX) in Hemoglobin Level Changes in Adults Aged 18 and Above With Iron Deficiency Anemia (EFFICACIOUS IRON)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
111 (estimated)
Sponsor
Dr. Anil K. Gupta Medicine Professional Corporation · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Iron deficiency anemia (IDA) is a widespread condition affecting many people globally. Despite the many cases of IDA, there are few studies that compare the effectiveness of different types of iron supplements with a greater emphasis on the cost of supplements and their tolerability. This study aims to conduct a comparison between different iron supplements to determine the superiority of the iron supplements Ferrous Ascorbate (EBMfer) and Ferrous Fumarate (Eurofer) over polysaccharide iron (FeraMax). This comparison will be conducted by determining the change in hemoglobin levels for participants in this trial over a 3-month period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFerrous FumarateFerrous Fumarate - 300 mg
DIETARY_SUPPLEMENTPolysaccharide IronPolysaccharide Iron - 150 mg
DIETARY_SUPPLEMENTFerrous AscorbateFerrous Ascorbate - 100 mg

Timeline

Start date
2024-02-24
Primary completion
2025-02-01
Completion
2025-02-01
First posted
2024-03-12
Last updated
2024-03-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06303531. Inclusion in this directory is not an endorsement.